About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 6573 record(s)
Req # A-2020-000717
Adverse Reaction Reports (AERs) for C1 Esterase Inhibitor. Report numbers: E2B_03054617, E2B_03152224. (AERs) for CUVITRU. Report numbers: 000911226, 000912204, 000912208. (AERs) for GAMMAGARD LIQUID. Report numbers: 000735871, 000736255,…Organization: Health Canada
March 2021
Req # A-2020-000803
Adverse Reaction Reports (AERs). Report numbers: E2B_03076723, 000912767, E2B_03006384, E2B_03206616, E2B_02720850, E2B_03224385.Organization: Health Canada
March 2021
Req # A-2020-000811
Adverse Reaction Reports (AERs). Report numbers: 000914955, 000914937, 000916806, 000917031, E2B_03199850, E2B_03226310, E2B_03253116.Organization: Health Canada
March 2021
Req # A-2020-000854
Adverse Reaction Reports (AERs). Report numbers: E2B_03186049, E2B_03186050, E2B_03192501, E2B_03193214.Organization: Health Canada
March 2021
Req # A-2020-000858
Adverse Reaction Reports (AERs). Report numbers: E2B_03146211, E2B_02894191, E2B_02196126, 000712016, E2B_01728270, E2B_02224950, E2B_02299168, E2B_02553170, 000716624, 000716626.Organization: Health Canada
March 2021
Req # A-2020-000889
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110509-318, Laboratories Canada Overview.Organization: Health Canada
March 2021
Req # A-2020-000898
Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 20-110420-68.Organization: Health Canada
March 2021
Req # A-2020-000957
Adverse Reaction Reports (AERs). Report numbers: 000917827, E2B_02360289, 000909666, E2B_02910123, E2B_03007640, E2B_02951340, E2B_03083997, E2B_02963400.Organization: Health Canada
March 2021
Req # A-2020-000993
Adverse Reaction Reports (AERs) for HYDROXYCHLOROQUINE SULFATE. Report numbers: E2B_01354481, E2B_02405078.Organization: Health Canada
March 2021
Req # A-2020-001032
Adverse Reaction Reports (AERs). Report numbers: 000708798, 000712724, 000714873, 000715028, 000717547, 000718705, 000719498, 000719659, 000719673, 000719684, 000719711, 000719764, 000720568, 000721089, 000721096, 000721104, 000721234, 000721241,…Organization: Health Canada
March 2021